Stay updated on Depemokimab in Severe Asthma Clinical Trial

Sign up to get notified when there's something new on the Depemokimab in Severe Asthma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Depemokimab in Severe Asthma Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    The page’s footer was updated to reflect a newer ClinicalTrials.gov revision version (v3.5.3). A previously listed journal publication citation was removed from the Publications section.
    Difference
    0.0%
    Check dated 2026-04-26T15:21:44.000Z thumbnail image
  4. Check
    32 days ago
    Change Detected
    Summary
    IQVIA Pty Ltd was added to the Collaborators and Investigators section and Iqvia Pty Ltd was removed, reflecting capitalization normalization of the organization name.
    Difference
    0.0%
    Check dated 2026-04-12T09:19:14.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    Publications section updated with a new reference: Early and Sustained Efficacy of Depemokimab in Type 2 Asthma: A Pooled Analysis of the SWIFT-1/-2 Studies.
    Difference
    0.0%
    Check dated 2026-04-05T06:20:59.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    A new publication citation has been added: Heffler E et al., Depemokimab demonstrates efficacy in patients with type 2 asthma with comorbid CRSwNP: Phase III SWIFT-1/-2 analysis. Front Allergy, 2026.
    Difference
    0.0%
    Check dated 2026-03-29T00:17:03.000Z thumbnail image
  7. Check
    53 days ago
    Change Detected
    Summary
    Revision: v3.5.0 has been added to the page. The previous revision entry, v3.4.3, has been removed.
    Difference
    0.0%
    Check dated 2026-03-21T17:11:14.000Z thumbnail image
  8. Check
    68 days ago
    Change Detected
    Summary
    Added a new publication entry for Safety and Tolerability of Twice-Yearly Depemokimab in Patients with Asthma and Chronic Rhinosinusitis with Nasal Polyps: Pooled Results from SWIFT-1/-2 and ANCHOR-1/-2 (Adv Ther, 2026; doi: 10.1007/s12325-025-03457-4) and removed the 2025 ahead-of-print reference. The study record version has been updated to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-07T09:28:25.000Z thumbnail image

Stay in the know with updates to Depemokimab in Severe Asthma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Depemokimab in Severe Asthma Clinical Trial page.